-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Xenon Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2013 to Q3 2024.
- Xenon Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 77.9M shares, a 18.1% increase year-over-year.
- Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 66.9M shares, a 10.5% increase from 2022.
- Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 60.5M shares, a 38.8% increase from 2021.
- Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 43.6M shares, a 26.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)